Topical Medications for Onychomycosis
For mild onychomycosis affecting less than 80% of the nail plate without lunula involvement, use amorolfine 5% lacquer applied once or twice weekly for 6-12 months as first-line topical therapy. 1
When Topical Therapy is Appropriate
Topical antifungals are limited to specific presentations 1:
- Superficial white onychomycosis (except transverse or striate patterns)
- Early distal lateral subungual onychomycosis (except with longitudinal streaks)
- Less than 80% nail plate involvement
- No lunula involvement
- When systemic antifungals are contraindicated
The nail plate's hard keratin structure creates a formidable barrier—drug concentration can drop 1000-fold from outer to inner surface, which explains the modest efficacy of topical agents 1.
First-Line Topical Options
Amorolfine 5% Lacquer (Strength of Recommendation D)
- Application: Once or twice weekly for 6-12 months 1
- Efficacy: Approximately 50% effectiveness in distal nail onychomycosis 1
- Adverse effects: Rare—local burning, pruritus, erythema 1
- Key advantage: Once-weekly application is as effective as twice-weekly 1
- File down diseased nail areas before each application
Efinaconazole 10% Solution (FDA-Approved)
Based on high-quality evidence, efinaconazole is superior to vehicle with 2:
- Complete cure rate: 3.54 times higher than vehicle (RR 3.54,95% CI 2.24-5.60)
- Clinical cure rate: 3.07 times higher (RR 3.07,95% CI 2.08-4.53)
- Application: Once daily for 48 weeks
- Adverse effects: Slightly increased risk (RR 1.10)—dermatitis and vesicles most common
- Note: Can be considered off-label for maintenance therapy to prevent recurrence 3
Tavaborole 5% Solution (FDA-Approved)
Moderate-to-high quality evidence shows 2:
- Complete cure rate: 7.40 times higher than vehicle (RR 7.40,95% CI 2.71-20.24)
- Mycological cure: 3.40 times higher (RR 3.40,95% CI 2.34-4.93)
- Application: Once daily for 48 weeks
- Adverse effects: Higher risk (RR 3.82)—application site reactions predominate
Alternative Topical Options
Ciclopirox 8% Lacquer (Strength of Recommendation C)
- Application: Once daily for up to 48 weeks 1
- Efficacy: Lower than amorolfine—34% mycological cure vs. 10% placebo, but only 8% clinical cure 1
- Duration: Up to 24 weeks for fingernails, 48 weeks for toenails 1
- Adverse effects: Periungual and nail fold erythema 1
- Best for: Patients where systemic therapy is contraindicated 1
Tioconazole 28% Solution (Strength of Recommendation D)
- Application: Twice daily for 6-12 months 1
- Efficacy: Only 22% mycological and clinical cure in open studies 1
- Adverse effects: Allergic contact dermatitis is not uncommon 1
- Contraindication: Pregnancy; men should avoid fathering children for 6 months post-therapy 1
Critical Limitations of Topical Therapy
Important caveat: Clinical improvement with topical antifungals often exceeds mycological cure by approximately 30% 1. This means the nail may look better while fungus persists, leading to recurrence.
Complete cure rates with topical treatments remain relatively low even with the best agents 2. When more than 80% of the nail is affected or the lunula is involved, combination treatment with systemic antifungals is recommended rather than topical monotherapy 1.
Practical Application Tips
Before each application 1:
- File down as much diseased nail as possible
- Clean the nail surface
- Apply the medication according to specific product instructions
For shoes and prevention 1:
- Discard old, moldy footwear when possible
- Alternative: Place naphthalene mothballs in shoes, seal in plastic bag for minimum 3 days
- Apply antifungal powders (miconazole, clotrimazole, tolnaftate) in shoes
- Treat all infected family members simultaneously
Device-Based Treatments
1064-nm Nd:YAG laser compared to no treatment or sham 2:
- Very low-quality evidence for efficacy
- May show little or no difference in mycological cure at 52 weeks (RR 1.04,95% CI 0.59-1.85)
- Uncertain adverse event profile
- FDA-approved only for "temporary increases in clear nail," not cure